Viromed Medical AG · ISIN: DE000A3MQR65 · Directors Dealings
Insider Transaction Snapshot

Viromed Medical AG

Directors Dealings: 20th November 2024
Reporting obligation triggered by: Perbandt, Uwe
Trading volume: 29.272,84 EUR
Type: Buy

The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 15th November 2024. The order was executed at the trading place Xetra. The aggregated volume was 29.272,84 EUR, based on an average price of 2,25 EUR. The nature of the Investment was Buy.

Short Selling Radar - Net Short Selling Positions

EQS-Newswire - Latest Company News, Ad-hoc News, Research

Directors Dealings

Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.

Reset filter
This might be interesting for you as well
New DD.i/o
19 November 2024
Blue Cap AG: A reportable insider transaction was published on 19th November 2024. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 19th November 2024,

The Insider Transaction was made by von Kottwitz, Dr Henning . The transaction toke place on 18th November 2024. The order was executed at the trading place Xetra. . The aggregated volume was 8.350,00 EUR, based on an average price of 16,70 EUR. The nature of the Investment was Buy.

Blue Cap AG
14 March 2024
Blue Cap AG: A reportable insider transaction was published on 14th March 2024. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 14th March 2024,

The Insider Transaction was made by Eschweiler, Jens Henning . The transaction toke place on 13th March 2024. The order was executed at the trading place Tradegate. . The aggregated volume was 35.730,00 EUR, based on an average price of 17,86 EUR. The nature of the Investment was Buy.

Blue Cap AG
25 October 2023
Blue Cap AG: A reportable insider transaction was published on 25th October 2023. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 25th October 2023,

The Insider Transaction was made by Eschweiler, Jens Henning . The transaction toke place on 24th October 2023. The order was executed at the trading place Tradegate. . The aggregated volume was 29.955,00 EUR, based on an average price of 14,98 EUR. The nature of the Investment was Buy.

Blue Cap AG
More Blue Cap AG related information
Type Total Last Made by Go to
Equity Story 61 23rd October 2024 EQS Group AG EQS
Corporate Research 0 - - Corporate Research
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

Important note:
The information presented here is usually updated once a day. Insofar as you include insider information/director dealings in your daily investment decisions and time-critical parameters play a role in the implementation of your trading strategy, you can obtain this information via a corresponding query at the BaFin or by monitoring the EQS-News intraday publications. 


Further information on the topic can be found on the following pages:

https://www.bafin.de/EN/Aufsicht/BoersenMaerkte/Transparenz/InformationspflichtenEmittenten/DirectorsDealings/directorsdealings_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2016/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/Aufsicht/BoersenMaerkte/Marktmissbrauch/Insiderueberwachung/insiderueberwachung_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2017/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/PublikationenDaten/Datenbanken/DirectorsDealings/directorsdealings_node.html